# Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010)

> **NCT01337674** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 26 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** MK-4618
- **DRUG:** Placebo for MK-4618
- **DRUG:** Metoprolol
- **DRUG:** Amlodipine

## Key facts

- **NCT ID:** NCT01337674
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04-01
- **Primary completion:** 2011-11-01
- **Final completion:** 2011-11-01
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2018-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01337674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01337674, "Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01337674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*